or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    APTO F Aptose Biosciences, Inc. 0.00
    ACLX F Arcellx, Inc. -5.67
    AVBP D ArriVent BioPharma, Inc. -1.61
    ARWR F Arrowhead Research Corporation -10.68
    ATRA F Atara Biotherapeutics, Inc. -2.91
    BCEL F Atreca, Inc. -3.12
    BPTH F Bio-Path Holdings Inc -3.20
    CASI F CASI Pharmaceuticals, Inc. 1.03
    CERO F CERo Therapeutics Holdings, Inc. 0.00
    CLDI F Calidi Biotherapeutics, Inc. 1.72
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Medicine Cancer Biotechnology Drugs Clinical Medicine Immune System Monoclonal Antibodies Antibodies Cancer Immunotherapy Cancer Treatment Carcinoma Checkpoint Inhibitor Disease Hematological Cancers Immunology Immunotherapies Immunotherapy Lymphoma Multiple Myeloma Non Small Cell Lung Cancer

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    PTH D Invesco DWA Healthcare Momentum ETF 2.96
    SBIO D ALPS Medical Breakthroughs ETF 2.78
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 2.78
    CNCR D Loncar Cancer Immunotherapy ETF 2.59
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 0.96
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare PTH to LABD Compare SBIO to BBC Compare SBIO to LABD

        Solid Tumors Stocks Recent News

        Date Stock Title
        May 10 ACLX Arcellx Inc (ACLX) Q1 2024 Earnings: Narrower Losses and Revenue Surge
        May 10 ARWR Arrowhead Pharmaceuticals Reports Substantial Fiscal Q2 Loss, Diverging from Analyst Expectations
        May 10 ARWR Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) Q2 2024 Earnings Call Transcript
        May 10 ACLX Arcellx GAAP EPS of -$0.14, revenue of $39.3M
        May 10 ACLX Kite and Arcellx prepare to launch Phase III multiple myeloma trial
        May 10 ARWR Arrowhead Pharmaceuticals, Inc. (ARWR) Q2 2024 Earnings Call Transcript
        May 9 ATRA Atara Biotherapeutics GAAP EPS of -$0.23 beats by $0.02, revenue of $27.36M beats by $2.67M
        May 9 ATRA Atara Biotherapeutics (ATRA) Reports Q1 Loss, Tops Revenue Estimates
        May 9 ACLX Gilead's Kite, Arcellx share phase 3 trial design for CAR-T multiple myeloma asset
        May 9 ACLX Arcellx, Inc. (ACLX) Reports Q1 Loss, Tops Revenue Estimates
        May 9 ACLX Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
        May 9 ACLX Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
        May 9 ARWR Arrowhead Pharmaceuticals GAAP EPS of -$1.02 misses by $0.80
        May 9 ATRA Atara Biotherapeutics Announces First Quarter 2024 Financial Results and Operational Progress
        May 9 ARWR Arrowhead Pharmaceuticals Reports Fiscal 2024 Second Quarter Results
        May 9 ACLX Arcellx Provides First Quarter 2024 Financial Results
        May 8 ARWR Arrowhead Pharmaceuticals Q2 2024 Earnings Preview
        May 8 AVBP ArriVent BioPharma reports Q1 results
        May 8 AVBP ArriVent BioPharma Reports First Quarter 2024 Financial Results
        May 7 ACLX Arcellx to Participate in Two Upcoming Investor Conferences
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Medicine Cancer Biotechnology Drugs Clinical Medicine Immune System Monoclonal Antibodies Antibodies Cancer Immunotherapy Cancer Treatment Carcinoma Checkpoint Inhibitor Disease Hematological Cancers Immunology Immunotherapies Immunotherapy Lymphoma Multiple Myeloma Non Small Cell Lung Cancer
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags